Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16484433 | 0.97 | ACHE (0.31) | — | |
| SCHEMBL17108995 | 0.90 | KDM4E (0.35) | KDM4EATML3MBTL1FEN1HSD17B10 | |
| SCHEMBL17108966 | 0.89 | MEN1 (0.34) | KDM4EATML3MBTL1FEN1HSD17B10 | |
| SCHEMBL17108976 | 0.88 | KDM4E (0.39) | KDM4EATML3MBTL1FEN1HSD17B10 | |
| SCHEMBL16484643 | 0.87 | ATM (0.41) | KDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL17108985 | 0.86 | KDM4E (0.40) | KDM4EATML3MBTL1FEN1 | |
| SCHEMBL16483876 | 0.85 | ACHE (0.30) | — | |
| SCHEMBL10451333 | 0.84 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL15335605 | 0.84 | KDM4E (0.38) | KDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL13772545 | 0.84 | KDM4E (0.39) | KDM4EATML3MBTL1FEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | YBX1, ATXN2L, ATXN2 | KDM4E 2405/4885ATM 3393/4885L3MBTL1 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.